PhD Scientific Days 2026

Budapest, 16-18 June 2026

Molecular Medicine 1.

The Sigma-1 Receptor Agonist Fluvoxamine Is Protective in Hyperglycaemia-Induced Dysfunction of Trabecular Meshwork Cells

Name of the presenter

Rozsahegyi, Alexandra

Institute/workplace of the presenter

Semmelweis University, Pediatric Center, Bókay Street

Authors

Alexandra Rozsahegyi1,2, Marcell Cserhalmi1, Timea Medveczki1,2, Zsuzsanna Buzogany1,2, Eva Ruisanchez3,4, Andras Budai5, Balazs Besztercei3, Attila J Szabo2, Judit Hodrea1,2, Andrea Fekete1,2

1: MTA-SE Lendület “Momentum” Diabetes Research Group, 1083 Budapest, Hungary;
2: Pediatric Center, MTA Center of Excellence, Semmelweis University, 1083 Budapest, Hungary;
3: Institute of Translational Medicine, Semmelweis University, 1094 Budapest, Hungary;
4: HUN-REN-SU Cerebrovascular and Neurocognitive Disorders Research Group, 1094 Budapest, Hungary
5: Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, 1091 Budapest, Hungary